StockData
Medtronic plc logo

Medtronic plc (MDT) operating KPIs

MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value
$96.54−0.57 (-0.59%)

Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%

Medtronic cardiac Rhythm & Heart Failure (CRHF — Legacy through FY2026Q4) — Worldwide Revenue ($M) ($M)

Effective Q1 FY2027, Medtronic reorganized Cardiovascular from 3 divisions (CRHF, SHA, CPV) into 4 divisions (EP Therapies, IC Therapies, CV Surgery, PV Health) without publishing Q2–Q4 FY2026 restated quarters yet; legacy 3 divisions are retained through FY2026Q4 per Step 5, while new divisions (<3 consecutive quarters) are in excluded.

Latest, FY2026
7,504
Period ended Apr 30, 2026
Change on a year earlier
+17.4%
6,392 in FY2025
History
12 years
Since FY2015
Sources
11
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Breakdown

What makes up cardiac rhythm & heart failure (crhf — legacy through fy2026q4) — worldwide revenue ($m)

Cite this data

StockData. (2026). Medtronic Cardiac Rhythm & Heart Failure (CRHF — Legacy through FY2026Q4) — Worldwide Revenue ($M) ($M), annual FY2015–FY2026 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/cv-crhf-leg-ww-rev

See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.